Home › Type 2 Diabetes › Florida › St. Petersburg
Type 2 Diabetes clinical trials in St. Petersburg, FL
5 studies for Type 2 Diabetes are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- IMA Clinical Research St. Petersburg, St. Petersburg
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Eirvera, LLC, St. Petersburg
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Recruiting
- Orlando Health, St. Petersburg
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Recruiting
- Orlando Health, St. Petersburg
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
RecruitingObservational study
- Johns Hopkins All Children's Hospital, St. Petersburg
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Miami, FL19 studies
- Dallas, TX19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in St. Petersburg
- Non-Small Cell Lung Cancer21 studies
- Breast Cancer11 studies
- Overweight9 studies
- Obesity9 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Endometrial Cancer6 studies
- Ovarian Cancer6 studies
- Burkitt Lymphoma6 studies
- Atopic Dermatitis (Eczema)5 studies
- Bladder Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.